Skip to content

Research on the application of multimodal prenatal screening programs in pregnancy in reducing birth defects

Research on the application of multimodal prenatal screening programs in pregnancy in reducing birth defects

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091345
Enrollment
Unknown
Registered
2024-10-27
Start date
2023-03-08
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Birth Defect

Interventions

Group A of simple young pregnant women:N/A
Group B of non-pure young pregnant women :N/A
Group C of simple elderly pregnant women:N/A
Group D of non-pure elderly pregnant women:N/A

Sponsors

The First Affiliated Hospital of Shihezi University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Live pregnancy (menstrual week, the last menstruation; for irregular menstruation, fetal double roof diameter and femur length were used to determine the gestational week). Single spontaneous pregnancy, regular prenatal examination in our hospital. Each pregnant woman was asked about family genetic history, disease history, abnormal pregnancy history and contact history of pregnancy risk factors. Inclusion criteria for simple pregnant women: ? Pre-birth age 35 years ? singleton natural conception ? no adverse pregnancy history ? no abnormal ultrasound structure and ultrasound soft index; Inclusion criteria for advanced age with high risk factors: ? Pre-birth age of 35 ? single natural conception ? with adverse pregnancy history (such as recurrent abortion, retained abortion, etc.) ? with abnormal ultrasound structure and ultrasound soft index; Inclusion criteria for young pregnant women alone: ? Serological screening for low-risk ? pregnant women who missed the serological screening time and required non-invasive genetic testing had normal ? ultrasound findings and no history of adverse pregnancy.

Exclusion criteria

Exclusion criteria: Pregnant women exclude moderate obesity (constitution index> 40), embryo transfer pregnancy or twin, multiple pregnancy, previous chromosome abnormalities fetal induction or childbirth, accept cell therapy, tumor patients, transplant and allogeneic blood transfusion within a year, there are amniotic cavity puncture contraindications, such as pregnant women with bleeding tendency, threatened abortion, active chronic pathogen infection or fever, NIPT detection failure, NIPT, amniotic cavity puncture results or pregnancy outcome data is incomplete.

Design outcomes

Primary

MeasureTime frame
Serological screening;NT;NIPT plus;System ultrasound;

Countries

China

Contacts

Public ContactYajuan Gu

Department of Obstetrics, the First Affiliated Hospital of Shihezi University

2584049853@qq.com+86 187 0309 6536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026